Marker Therapeutics, Inc. Balance Sheet
MRKR|3 years of annual SEC 10-K data (FY2018-FY2021)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Marker Therapeutics, Inc. had $68M in total assets and $44M in shareholders' equity as of FY2021.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2021 | FY2019 | FY2018 |
|---|---|---|---|
| Cash & Equivalents | $42.4M | $43.9M | $61.7M |
| Current Assets | $46.0M | $45.5M | $62.0M |
| PP&E (Net) | $12.3M | $418.0K | $147.7K |
| Total Assets | $68.1M | $46.4M | $62.1M |
| Current Liabilities | $12.9M | $2.0M | $2.8M |
| Shareholders' Equity | $44.0M | $44.1M | $3.7M |